» Articles » PMID: 37651065

Comprehensive Analysis of Circular RNAs in Nasopharyngeal Cancer

Overview
Journal Genes Genomics
Specialty Genetics
Date 2023 Aug 31
PMID 37651065
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Nasopharyngeal cancer (NPC) is a type of epithelial malignancy that is positive for Epstein-Barr virus (EBV) and affects several populations worldwide. Due to the high rates of relapse and metastasis following primary treatment, there is an urgent need to identify new candidates for NPC therapy. Recently, circular RNA (circRNA) has emerged as a promising target for cancer diagnosis and prevention.

Objective: This study aimed to study the circRNAs enriched in NPC patients, and further analyze potential signaling pathways involved.

Methods: A new bioinformatic tool named psirc was used to analyze RNA-sequencing datasets from NPC patients and normal specimens to study the NPC-enriched circRNAs.

Results: We identified and quantified the full-length circRNA in these samples and found the top 10 enriched circRNAs in NPC patients compared to control samples. Furthermore, we selected the most enriched circRNA, circEEF1A1_E8B1, and studied its protein coding ability, microRNA and RNA-binding protein (RBP) binding capacity. We also constructed a protein-protein interaction (PPI) network for its binding proteins and extracted hub genes. Finally, we conducted survival analysis for these hub genes in head and neck cancer patients.

Conclusions: In summary, our study has revealed the presence of previously unidentified circRNAs that are enriched in NPC patients. Through an analysis of their molecular functions, we have advanced our understanding of the potential role of circRNAs in NPC development.

Citing Articles

Roles and mechanisms of circular RNA in respiratory system cancers.

Yang N, Jiao M, Zhang Y, Mo S, Wang L, Liang J Front Oncol. 2024; 14:1430051.

PMID: 39077467 PMC: 11284073. DOI: 10.3389/fonc.2024.1430051.


An Evaluation of Treatment Outcomes and Associated Factors in Nasopharyngeal Cancer Patients at a Tertiary Cancer Center in the United Arab Emirates.

Bin Sumaida A, Shanbhag N, Aby Ali H, Jaafar N, AlKaabi K, Balaraj K Cureus. 2024; 16(2):e54344.

PMID: 38371438 PMC: 10873819. DOI: 10.7759/cureus.54344.

References
1.
Agarwal V, Bell G, Nam J, Bartel D . Predicting effective microRNA target sites in mammalian mRNAs. Elife. 2015; 4. PMC: 4532895. DOI: 10.7554/eLife.05005. View

2.
Ahringer J . NuRD and SIN3 histone deacetylase complexes in development. Trends Genet. 2000; 16(8):351-6. DOI: 10.1016/s0168-9525(00)02066-7. View

3.
Arimbasseri A, Rijal K, Maraia R . Comparative overview of RNA polymerase II and III transcription cycles, with focus on RNA polymerase III termination and reinitiation. Transcription. 2015; 5(1):e27639. PMC: 4214234. DOI: 10.4161/trns.27369. View

4.
Ayer D . Histone deacetylases: transcriptional repression with SINers and NuRDs. Trends Cell Biol. 1999; 9(5):193-8. DOI: 10.1016/s0962-8924(99)01536-6. View

5.
Bahn J, Zhang Q, Li F, Chan T, Lin X, Kim Y . The landscape of microRNA, Piwi-interacting RNA, and circular RNA in human saliva. Clin Chem. 2014; 61(1):221-30. PMC: 4332885. DOI: 10.1373/clinchem.2014.230433. View